Management Team
Reza Shekarriz, Founder/CEO
- Entrepreneur and visionary, leading tech development in several companies with demonstrated hands-on skills in management and leadership
- 25 Years of experience in product-driven R&D within private and national lab environment, with over 100 publications/reports and patents
- Innovative microfluidic, acoustofluidic, optoelectronic, and electrohydrodynamic sample prep and sensing products launch and commercialization
- Expertise in small business launch, growth, and exit
- PhD in Mechanical Engineering from WSU and post-doc at the Johns Hopkins University
Robert Beckius, Director of Engineering
- Technologist with more than 20 years of management and product/device development and commercialization;
- Expertise in ISO-9000 device qualification and quality systems and standards implementation;
- Instrument and device development engineering experience at MetOne Instruments and IcX Technologies;
- BS in mechanical engineering from Montana State University, Bozeman, MT, with training and expertise on efficient mass production and high-volume manufacturing.
Reza Shekarriz, Founder/CEO
- Entrepreneur and visionary, leading tech development in several companies with demonstrated hands-on skills in management and leadership
- 25 Years of experience in product-driven R&D within private and national lab environment, with over 100 publications/reports and patents
- Innovative microfluidic, acoustofluidic, optoelectronic, and electrohydrodynamic sample prep and sensing products launch and commercialization
- Expertise in small business launch, growth, and exit
- PhD in Mechanical Engineering from WSU and post-doc at the Johns Hopkins University
Robert Beckius, Director of Engineering
- Technologist with more than 20 years of management and product/device development and commercialization;
- Expertise in ISO-9000 device qualification and quality systems and standards implementation;
- Instrument and device development engineering experience at MetOne Instruments and IcX Technologies;
- BS in mechanical engineering from Montana State University, Bozeman, MT, with training and expertise on efficient mass production and high-volume manufacturing.
Business Strategy Partnership
Heather Ferguson, PhD, MBA
- PhD Toxicologist with more than 15 years experience in medical device quality, regulatory and operations;
- CEO of QRT Consulting focused on getting medical devices into the market;
- Director Quality Operations, Cardinal Health North America Manufacturing
- Global Program Manager, Operations Manager, and Director of Regulatory Toxicology, Abbott
Gary Cohn, PLLC
- More than 35 years of practice in business law, patent/IP protection and B2B agreements;
- Expertise in small tech companies, including medical diagnostics and device manufacturers;
- 25 years as counsel for Dow Chemical with more than 500 issued patents;
- BS Chemistry Univ. of Notre Dame and J.D. from Rutgers Univ. Law School
Heather Ferguson, PhD, MBA
- PhD Toxicologist with more than 15 years experience in medical device quality, regulatory and operations;
- CEO of QRT Consulting focused on getting medical devices into the market;
- Director Quality Operations, Cardinal Health North America Manufacturing
- Global Program Manager, Operations Manager, and Director of Regulatory Toxicology, Abbott
Gary Cohn, PLLC
- More than 35 years of practice in business law, patent/IP protection and B2B agreements;
- Expertise in small tech companies, including medical diagnostics and device manufacturers;
- 25 years as counsel for Dow Chemical with more than 500 issued patents;
- BS Chemistry Univ. of Notre Dame and J.D. from Rutgers Univ. Law School
R&D and Clinical Partnership
Ross Clark, MD, MBA, FACS, RPVI
- Vascular surgeon specializing in lower extremity revascularization and amputations
- Research focused on angiogenesis and wound healing of patients with peripheral artery disease (PAD) and chronic limb threatening ischemia (CLTI)
- Assistant Professor at UNM Dept. of Surgery and active member of the UNM hydrogen sulfide (H2S) signaling molecule research group
- Board certified in General and Vascular Surgery, American Board of Surgery
- MD and MBA from UNM. Vascular fellowship training at Vanderbilt University Medical Center
Nancy Kanagy, PhD
- Pharmacologist with experience and international recognition in cardiovascular physiology and hydrogen sulfide (H2S) signaling and endothelial cell biology
- Professor and Dept. Head, UNM Cell Biology and Physiology
- Fellow of APS, AHA and standing member of review committees at NHLBI and AHA;
- Associate editor of the American Journal of Heart & Circulatory Physiology
- PhD in Cardiovascular Pharmacology from Michigan State University and fellowship at the University of Michigan in Cardiovascular Physiology
Eric Lew, MD, DPM
- Podiatry and wound care specialist at UNM hospital and UNM Medical Groups, Inc.
- Active member in the Limb Salvage & Reconstructive Surgery Programs such as the Southern Arizona Limb Salvage Alliance (SALSA) and Center of Healing in Lower Extremity (CHILE)
- Founder of the UNM Orthopedics and Diabetic Comprehensive Care Specialists network
- Member of American Board of Orthopedic & Podiatric Medicine, American Board of Foot & Ankle Surgery – Foot Surgery
- Residency Cleveland Clinic-Kaiser Permanente, Cleveland, Ohio; MD from Des Moines College of Podiatric and Surgery
Prof. Cristine Heaps, PhD
- Professor and Associate Department Head, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University
- Expertise in vascular biology and physiology and Ph.D. in Physiology, University of Missouri, Columbia, Missouri
- Experience in animal models of cardiovascular disease, and exercise training
- Research focus on cellular mechanisms that control blood flow in healthy and diseased organs
- Long history of use of porcine models for biomedical research in highly clinically relevant studies
Ross Clark, MD, MBA, FACS, RPVI
- Vascular surgeon specializing in lower extremity revascularization and amputations
- Research focused on angiogenesis and wound healing of patients with peripheral artery disease (PAD) and chronic limb threatening ischemia (CLTI)
- Assistant Professor at UNM Dept. of Surgery and active member of the UNM hydrogen sulfide (H2S) signaling molecule research group
- Board certified in General and Vascular Surgery, American Board of Surgery
- MD and MBA from UNM. Vascular fellowship training at Vanderbilt University Medical Center
Nancy Kanagy, PhD
- Pharmacologist with experience and international recognition in cardiovascular physiology and hydrogen sulfide (H2S) signaling and endothelial cell biology
- Professor and Dept. Head, UNM Cell Biology and Physiology
- Fellow of APS, AHA and standing member of review committees at NHLBI and AHA;
- Associate editor of the American Journal of Heart & Circulatory Physiology
- PhD in Cardiovascular Pharmacology from Michigan State University and fellowship at the University of Michigan in Cardiovascular Physiology
Eric Lew, MD, DPM
- Podiatry and wound care specialist at UNM hospital and UNM Medical Groups, Inc.
- Active member in the Limb Salvage & Reconstructive Surgery Programs such as the Southern Arizona Limb Salvage Alliance (SALSA) and Center of Healing in Lower Extremity (CHILE)
- Founder of the UNM Orthopedics and Diabetic Comprehensive Care Specialists network
- Member of American Board of Orthopedic & Podiatric Medicine, American Board of Foot & Ankle Surgery – Foot Surgery
- Residency Cleveland Clinic-Kaiser Permanente, Cleveland, Ohio; MD from Des Moines College of Podiatric and Surgery
Prof. Cristine Heaps, PhD
- Professor and Associate Department Head, School of Veterinary Medicine and Biomedical Sciences, Texas A&M University
- Expertise in vascular biology and physiology and Ph.D. in Physiology, University of Missouri, Columbia, Missouri
- Experience in animal models of cardiovascular disease, and exercise training
- Research focus on cellular mechanisms that control blood flow in healthy and diseased organs
- Long history of use of porcine models for biomedical research in highly clinically relevant studies
Vision
Become one of the recognized leading providers of medical devices for advanced wound care.
Mission
To develop non-invasive diagnostics and minimally invasive therapeutic technologies by employing the properties of H2S for detection and treatment of microvascular disease, PAD, and chronic, hard-to-heal wounds.